Scientists test 'Off-the-Shelf' cell therapy that may outlast cancer
NCT ID NCT06481735
Summary
This study is testing a new type of cell therapy for adults whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. Doctors take immune cells from healthy donors, genetically modify them to better target and fight leukemia cells, and infuse them into patients. The goal is to see if this 'off-the-shelf' approach is safe and effective, with early data suggesting these modified cells may persist longer in the body and avoid dangerous immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biotherapeutic Department of Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, 100853, China
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Hematology, Chinese PLA General Hospital
RECRUITINGBeijing, China
Contact
Contact
Contact
Contact
Contact
-
Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College
RECRUITINGChangzhi, China
Contact
-
Department of Hematology, Peking Union Medical College Hospital
NOT_YET_RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Hematology, Tianjin First Central Hospital
RECRUITINGTianjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Immune Cell Therapy Center, Blood Disease Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China
Contact
Conditions
Explore the condition pages connected to this study.